Abstract:The vines and leaves of Momordica charantia L. are used as herbal medicines to treat inflammation-related disorders. However, their safety profile remains uncharacterized, and the constituents in their extracts that exert anti-inflammatory and adverse effects remain unclear. This study isolated the characteristic cucurbitane-type triterpenoid species in the vines and leaves of M. charantia L. and analyzed their cytotoxicity, anti-inflammatory effects, and underlying mechanisms. Four structurally related triterpenoids—momordicines I, II, IV, and (23E) 3β,7β,25-trihydroxycucurbita-5,23-dien-19-al (TCD)—were isolated from the triterpenoid-rich fractions of extracts from the vines and leaves of M. charantia. Momordicine I was cytotoxic on normal cells, momordicine II exerted milder cytotoxicity, and momordicine IV and TCD had no obvious adverse effects on cell growth. TCD had anti-inflammatory activity both in vivo and in vitro. In lipopolysaccharide-stimulated RAW 264.7 cells, TCD inhibited the inhibitor kappa B kinase/nuclear factor-κB pathway and enhanced the expression of nuclear factor erythroid 2-related factor 2, heme oxygenase-1, and glutamate-cysteine ligase modifier subunit through the extracellular signal-regulated kinase1/2 and p38. Thus, the vines and leaves of M. charantia should be used with caution. An extraction protocol that can enrich TCD but remove momordicine I would likely enhance the safety of the extract.

Structures of New Triterpenoids and Cytotoxicity Activities of the Isolated Major Compounds from the Fruit of Momordica Charantia L.

Cucurbitane-type triterpenoids from the aerial parts of Momordica charantia L.

Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities.

Cucurbitane-type Triterpenoids from Momordica Charantia.

Cucurbitane-type triterpenoids from the leaves of Momordica charantia.

Cucurbitane-type triterpenoids from the stems of momordica charantia.

Cucurbitane-type triterpenoids from the vines of Momordica charantia and their anti-inflammatory, cytotoxic, and antidiabetic activity

Four New Cucurbitane-Type Triterpenes from Momordica Charantia L. with Their Cytotoxic Activities and Protective Effects on H2O2-damaged Pancreatic Cells

Cucurbitane-type triterpenoids from the fruit of Momordica charantia.

A New Cucurbitane Triterpenoid from Momordica Charantia

Novel compounds in Momordica charantia

New Compounds from Acid Hydrolyzed Products of the Fruits of Momordica Charantia L. and Their Inhibitory Activity Against Protein Tyrosine Phosphatas 1B.

Cytotoxic and Anti-Inflammatory Triterpenoids in the Vines and Leaves of Momordica charantia

Cucurbitane Triterpenoids from Momordica Charantia L. and Their Inhibitory Activity Against Α-Glucosidase, Α-Amylase and Protein Tyrosine Phosphatase 1B (PTP1B)

Evaluation of Cytotoxic Activity in vitro of Charantin A Extracted from Momordica charantia

Four New Cucurbitacins from the Fruit of Momordica Charantia

Two New Guaiane-Type Sesquiterpene Glycosides from the Fruits of Daucus Carota L.

New Cycloartane Triterpenes from the Aerial Parts of Cimicifuga Heracleifolia

Antiaging of Cucurbitane Glycosides from Fruits of Momordica Charantia L.

The Antigluconeogenic Activity of Cucurbitacins from Momordica Charantia

New Triterpenoids with Cytotoxic Activity from Actinidia Valvata.